RxDoctor Payments Data

Amy Kelley, MD

Internal Medicine · Columbus, OHNPI 1659321453

Payments from drug & device makers

$8,194in general payments, 2019–2025

Across 568 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$779
  • Novo Nordisk$658
  • AstraZeneca$488
  • Pfizer$411
  • Takeda Pharmaceuticals U.S.A., Inc.$339
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$8,162100%
  • Education$310%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,194 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$122,076
Medicare patients
346
Services billed
3,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$95,610
TrulicityDulaglutide67$73,026
EliquisApixaban54$61,841
JardianceEmpagliflozin31$50,363
FarxigaDapagliflozin Propanediol39$32,235
JanumetSitagliptin Phos/Metformin Hcl25$27,133
JanuviaSitagliptin Phosphate25$24,621
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$24,265
XareltoRivaroxaban18$24,234
MounjaroTirzepatide22$24,229
MyrbetriqMirabegron24$13,282
ShingrixVaricella-Zoster Ge/As01b/Pf37$8,317
SynthroidLevothyroxine Sodium62$4,378
Atorvastatin Calcium363$3,547
Rosuvastatin Calcium258$2,821

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$779$97,25689 claims
Novo NordiskOzempic$658$95,61069 claims
PfizerEliquis$411$61,84154 claims
MerckJanumet, Januvia$261$51,75350 claims
Boehringer IngelheimJardiance$254$50,36331 claims
GSKTrelegy Ellipta, Shingrix$275$32,58264 claims
AstraZenecaFarxiga$488$32,23539 claims
Johnson & JohnsonXarelto$332$24,23418 claims
Astellas Pharma US IncMyrbetriq$184$13,28224 claims
AbbVieSynthroid$1,553$4,37862 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →